Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea
· Delayed Price · Currency is KRW 1,079,000
+11,000 (1.03%)
Mar 12, 2025, 9:00 AM KST
Samsung Biologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 76,796,746 | 67,544,126 | 54,092,240 | 58,433,854 | 59,746,995 | 54,652,290 | Upgrade
|
| Market Cap Growth | 24.87% | 24.87% | -7.43% | -2.20% | 9.32% | 90.76% | Upgrade
|
| Enterprise Value | 76,951,697 | 67,525,830 | 54,470,492 | 57,778,382 | 59,669,232 | 54,358,190 | Upgrade
|
| Last Close Price | 1079000.00 | 949000.00 | 760000.00 | 821000.00 | 893509.47 | 817318.74 | Upgrade
|
| PE Ratio | 70.89 | 62.35 | 63.07 | 73.22 | 151.80 | 226.80 | Upgrade
|
| Forward PE | 60.73 | 62.18 | 60.08 | 82.37 | 112.20 | - | Upgrade
|
| PS Ratio | 16.89 | 14.85 | 14.64 | 19.47 | 38.10 | 46.92 | Upgrade
|
| PB Ratio | 7.04 | 6.19 | 5.50 | 6.50 | 11.97 | 11.88 | Upgrade
|
| P/TBV Ratio | 8.52 | 8.52 | 8.23 | 10.14 | 12.05 | 11.94 | Upgrade
|
| P/FCF Ratio | 215.91 | 189.90 | 80.60 | - | 1235.91 | 875.48 | Upgrade
|
| P/OCF Ratio | 40.71 | 40.71 | 32.46 | 61.31 | 131.43 | 270.44 | Upgrade
|
| PEG Ratio | 3.19 | 3.19 | 3.45 | 3.32 | 3.45 | - | Upgrade
|
| EV/Sales Ratio | 16.92 | 14.85 | 14.74 | 19.25 | 38.05 | 46.67 | Upgrade
|
| EV/EBITDA Ratio | 40.04 | 35.19 | 33.97 | 44.72 | 85.35 | 124.54 | Upgrade
|
| EV/EBIT Ratio | 58.18 | 51.15 | 48.91 | 58.74 | 111.05 | 185.66 | Upgrade
|
| EV/FCF Ratio | 216.35 | 189.85 | 81.16 | - | 1234.30 | 870.77 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.19 | 0.28 | 0.26 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.77 | 0.77 | 1.19 | 1.95 | 1.85 | 1.80 | Upgrade
|
| Debt / FCF Ratio | 4.18 | 4.18 | 2.84 | - | 26.74 | 12.57 | Upgrade
|
| Asset Turnover | 0.27 | 0.27 | 0.23 | 0.24 | 0.22 | 0.19 | Upgrade
|
| Inventory Turnover | 0.83 | 0.83 | 0.76 | 0.91 | 1.02 | 1.37 | Upgrade
|
| Quick Ratio | 0.35 | 0.35 | 0.49 | 0.76 | 1.24 | 1.45 | Upgrade
|
| Current Ratio | 1.43 | 1.43 | 1.33 | 1.54 | 2.55 | 2.97 | Upgrade
|
| Return on Equity (ROE) | 10.45% | 10.45% | 9.12% | 11.42% | 8.21% | 5.38% | Upgrade
|
| Return on Assets (ROA) | 4.94% | 4.94% | 4.27% | 5.01% | 4.67% | 2.97% | Upgrade
|
| Return on Capital (ROIC) | 6.84% | 6.84% | 5.99% | 6.91% | 5.76% | 3.52% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.79% | 9.79% | 9.37% | 7.93% | 7.83% | 5.02% | Upgrade
|
| Earnings Yield | 1.41% | 1.60% | 1.59% | 1.37% | 0.66% | 0.44% | Upgrade
|
| FCF Yield | 0.46% | 0.53% | 1.24% | -0.01% | 0.08% | 0.11% | Upgrade
|
| Buyback Yield / Dilution | - | -1.95% | -5.51% | - | - | Upgrade
| |
| Total Shareholder Return | - | -1.95% | -5.51% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.